Sort   by:  
 Page size 
ProteomicsChAdOx infection of human cell lines A549 MRC-5
Total proteome and phospho proteome of two human cell lines infected with the ChAdOx1 nCoV-19 virus over 72 hours
ORGANISM(S): Homo sapiens (Human) 
2021-01-11 | PXD023286 | Pride
Chadox ncov-19 Adenovirus Human 
UnknownLaboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
Not available
S-EPMC8645417 | biostudies-literature
UnknownAn Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901.
Not available
S-EPMC9146038 | biostudies-literature
UnknownEffectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Not available
S-EPMC9464812 | biostudies-literature
UnknownProtection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
Not available
S-EPMC10558771 | biostudies-literature
UnknownWho funded the research behind the Oxford-AstraZeneca COVID-19 vaccine?
Not available
S-EPMC8704023 | biostudies-literature
UnknownInfluence of individuals' determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination.
Not available
S-EPMC11111746 | biostudies-literature
UnknownSymptomatic post-vaccination SARS-CoV-2 infections in healthcare workers- A multicenter cohort study.
Not available
S-EPMC8489275 | biostudies-literature
UnknownDespite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Not available
S-EPMC10435738 | biostudies-literature
UnknownOn the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination.
Not available
S-EPMC9208546 | biostudies-literature
Sort   by:  
 Page size